CRCNS: A mechanistic theory of serotonergic modulation of cortical processing
CRCNS:皮质处理的血清素调节机制理论
基本信息
- 批准号:10645069
- 负责人:
- 金额:$ 33.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAgonistAnimalsAreaBackBrainCalciumCellsCodeDesire for foodDevelopmentElectrophysiology (science)EquilibriumFunctional Magnetic Resonance ImagingGlutamatesHTR2A geneHallucinationsHallucinogensHumanImageKnowledgeLinkLiteratureModelingMood DisordersMotivationMusNeuronsPaintPathway interactionsPerceptionPlayPopulationPyramidal CellsRecreationRecurrenceRewardsRoleSensoryStatistical MethodsStructureTestingTheoretical modelTherapeuticTimeTrainingVisualVisual CortexVisual evoked cortical potentialWorkcell typedesignexperimental studyneuralneural circuitneuromechanismneuropsychiatric disorderneuroregulationoptogeneticspredictive modelingpreventresponsespatiotemporaltheoriesvisual processing
项目摘要
Serotonergic neuromodulation is a crucial factor in regulating several aspects of brain function, from
mood disorders to appetite, reward and motivation, and in maintaining balance of sensory perception.
However, the network mechanisms by which it modulates brain dynamics are elusive. In this project,
we will develop and experimentally test a mechanistic theory explaining the observed modulations of
cortical activity induced by the serotonergic activation via hallucinogenic agonists. Existing evidence
paints an apparently contradictory picture, where a hallucinogenic HT2AR agonist increases pyramidal
cells’ excitability and glutamatergic levels while, at the same time, leading to a reduction in visually
evoked responses. Our central hypothesis is that these puzzling effects of serotonergic activation are
due to gain modulation induced in visual cortex (V1) circuits. The proposed mechanism is
counterintuitive as it leads to decreased evoked responses by way of increasing pyramidal cell
excitability, due to a counterintuitive effect produced by strong recurrent dynamics in cortical circuits; it
also leads to increased variability of network activity, and changes in brain-wide connectivity. By
expanding the repertoire of cortical states, it may explain the onset of hallucinations driven by
serotonergic activation. We will show how this mechanistic theory can reconcile the tension in the
literature and we will design and perform new experiments to test the model predictions in behaving
animals. Together, this project provides a link between cellular-level neuromodulation and the impact
on network dynamics and, ultimately, sensory perception.
血清素能神经调节是调节脑功能的几个方面的关键因素,从
情绪障碍对食欲、奖赏和动机的影响,以及对维持感官知觉平衡的影响。
然而,它调节大脑动力学的网络机制是难以捉摸的。在本项目中,
我们将开发和实验测试解释观察到的调制机制理论,
通过致幻激动剂由多巴胺能激活诱导的皮质活动。现有证据
描绘了一幅明显矛盾的画面,其中致幻HT 2AR激动剂增加了锥体细胞
同时,在视觉上,
诱发反应我们的中心假设是,这些令人困惑的β-肾上腺素能激活效应是
这是由于视觉皮层(V1)回路中诱导的增益调制。拟议的机制是
这是违反直觉的,因为它通过增加锥体细胞而导致诱发反应减少
兴奋性,由于皮层回路中强烈的循环动力学产生的反直觉效应;它
还导致网络活动的可变性增加,以及全脑连接的变化。通过
扩大了大脑皮层的状态,这可能解释了幻觉的发生,
肾上腺素能激活。我们将展示这种机械论如何能够调和
我们将设计和执行新的实验,以测试模型预测的行为,
动物总之,这个项目提供了细胞水平的神经调节和影响之间的联系,
网络动力学,最终,感官知觉。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A reservoir of timescales emerges in recurrent circuits with heterogeneous neural assemblies.
- DOI:10.7554/elife.86552
- 发表时间:2023-12-12
- 期刊:
- 影响因子:7.7
- 作者:Stern M;Istrate N;Mazzucato L
- 通讯作者:Mazzucato L
A reservoir of foraging decision variables in the mouse brain.
- DOI:10.1038/s41593-023-01305-8
- 发表时间:2023-05
- 期刊:
- 影响因子:25
- 作者:Cazettes, Fanny;Mazzucato, Luca;Murakami, Masayoshi;Morais, Joao P. P.;Augusto, Elisabete;Renart, Alfonso;Mainen, Zachary F. F.
- 通讯作者:Mainen, Zachary F. F.
Neural mechanisms underlying the temporal organization of naturalistic animal behavior.
- DOI:10.7554/elife.76577
- 发表时间:2022-07-06
- 期刊:
- 影响因子:7.7
- 作者:Mazzucato, Luca
- 通讯作者:Mazzucato, Luca
Estimating the Unique Information of Continuous Variables
- DOI:
- 发表时间:2021-01
- 期刊:
- 影响因子:0
- 作者:Ari Pakman;D. Gilboa;E. Schneidman
- 通讯作者:Ari Pakman;D. Gilboa;E. Schneidman
Multitasking via baseline control in recurrent neural networks.
通过循环神经网络中的基线控制进行多任务处理。
- DOI:10.1073/pnas.2304394120
- 发表时间:2023
- 期刊:
- 影响因子:11.1
- 作者:Ogawa,Shun;Fumarola,Francesco;Mazzucato,Luca
- 通讯作者:Mazzucato,Luca
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Luca Mazzucato其他文献
Luca Mazzucato的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Luca Mazzucato', 18)}}的其他基金
CRCNS: A mechanistic theory of serotonergic modulation of cortical processing
CRCNS:皮质处理的血清素调节机制理论
- 批准号:
10396147 - 财政年份:2021
- 资助金额:
$ 33.97万 - 项目类别:
CRCNS: A mechanistic theory of serotonergic modulation of cortical processing
CRCNS:皮质处理的血清素调节机制理论
- 批准号:
10435584 - 财政年份:2021
- 资助金额:
$ 33.97万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 33.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 33.97万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 33.97万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 33.97万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 33.97万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 33.97万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 33.97万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 33.97万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 33.97万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 33.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




